Neonatal Medicine

The Korean Society of Neonatology (대한신생아학회)
권호 표지
DOI QR코드

DOI QR Code

Adverse Events and Risk Factors Associated with Chloral Hydrate Sedation for Brain Magnetic Resonance Imaging in the Neonatal Intensive Care Unit

  • Park, Byeong Sub (Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine) ;
  • Yoo, Yeong Myong (Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine) ;
  • Noh, O Kyu (Department of Radiation Oncology, Ajou University Hospital, Ajou University School of Medicine) ;
  • Park, Moon Sung (Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine) ;
  • Lee, Jang Hoon (Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine)
  • Received : 2018.09.14
  • Accepted : 2019.01.15
  • Published : 2019.05.28
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study investigated the incidence of adverse events (AEs) and risk factors associated with sedation using chloral hydrate (CH) for brain magnetic resonance imaging (MRI) in the neonatal intensive care unit (NICU). Methods: This was a retrospective study of infants who received CH for brain MRI in the NICU. Among the enrolled infants (n=143), 12.6% (n=18) were included in the AE group and 87.4% (n=125) were in the non-adverse event group (NAE) Results: Gestational age (GA) at birth and corrected GA at sedation were 35+0±7+2 and 39+5±3+1 respectively. The rate of AEs was 12.6%, included oxygen desaturation (5.6%), aspiration (4.9%), paradoxical agitation (0.7%), tachycardia or bradycardia (0.7%), and arrest (0.7%). In univariate analysis, the AE group was younger in corrected GA at sedation than the NAE group (37+2 [range, 36+0 to 40+0] vs. 40+1 [range, 38+2 to 41+4], P=0.015). There was no significant difference in CH dosage (50.0 [range, 50.0 to 50.0] vs. 50.0 [range, 50.0 to 50.0], P=0.092), cardiopulmonary (33.3% [n=6] vs. 17.6% [n= 22], P=0.209) and central nervous system (61.1% [n=11] vs. 65.6% [n=82], P=0.054) morbidity. In multivariate analysis, CH dosage was the only significant risk factor for AEs associated with sedation (odds ratio, 1.04; 95% confidence interval, 1.01 to 1.07; P=0.0186). Conclusion: AEs associated with sedation using CH are not uncommon and should be considered when using high dose CH for diagnostic testing in the NICU.

Keywords

References

  1. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379:2162-72. https://doi.org/10.1016/S0140-6736(12)60820-4
  2. Doyle LW, Anderson PJ. Adult outcome of extremely preterm infants. Pediatrics 2010;126:342-51. https://doi.org/10.1542/peds.2010-0710
  3. Johnson S, Marlow N. Preterm birth and childhood psychiatric disorders. Pediatr Res 2011;69:11R-8R. https://doi.org/10.1203/PDR.0b013e318212faa0
  4. Tocchio S, Kline-Fath B, Kanal E, Schmithorst VJ, Panigrahy A. MRI evaluation and safety in the developing brain. Semin Perinatol 2015;39:73-104. https://doi.org/10.1053/j.semperi.2015.01.002
  5. Rose J, Vassar R, Cahill-Rowley K, Stecher Guzman X, Hintz SR, Stevenson DK, et al. Neonatal physiological correlates of near-term brain development on MRI and DTI in very-low-birth-weight preterm infants. Neuroimage Clin 2014;5:169-77. https://doi.org/10.1016/j.nicl.2014.05.013
  6. Rutherford M, Srinivasan L, Dyet L, Ward P, Allsop J, Counsell S, et al. Magnetic resonance imaging in perinatal brain injury: clinical presentation, lesions and outcome. Pediatr Radiol 2006;36:582-92. https://doi.org/10.1007/s00247-006-0164-8
  7. Woodward LJ, Anderson PJ, Austin NC, Howard K, Inder TE. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N Engl J Med 2006;355:685-94. https://doi.org/10.1056/NEJMoa053792
  8. Finnemore A, Toulmin H, Merchant N, Arichi T, Tusor N, Cox D, et al. Chloral hydrate sedation for magnetic resonance imaging in newborn infants. Paediatr Anaesth 2014;24:190-5. https://doi.org/10.1111/pan.12264
  9. Krauss BS, Krauss BA, Green SM. Procedural sedation and analgesia in children. N Engl J Med 2014;371:91. https://doi.org/10.1056/NEJMc1404371
  10. Heistein LC, Ramaciotti C, Scott WA, Coursey M, Sheeran PW, Lemler MS. Chloral hydrate sedation for pediatric echocardiography: physiologic responses, adverse events, and risk factors. Pediatrics 2006;117:e434-41. https://doi.org/10.1542/peds.2005-1445
  11. Lee J, Youn YA, Kim SJ, Lee HS, Kim SY, Sung IK, et al. Adverse effects of chloral hydrate in neonates: frequency and related factors. J Korean Soc Neonatol 2011;18:130-6. https://doi.org/10.5385/jksn.2011.18.1.130
  12. Cote CJ, Wilson S. Guidelines for monitoring and management of pediatric patients before, during, and after sedation for diagnostic and therapeutic procedures: update 2016. Pediatr Dent 2016;38:13-39.
  13. Wheeler DS, Jensen RA, Poss WB. A randomized, blinded comparison of chloral hydrate and midazolam sedation in children undergoing echocardiography. Clin Pediatr 2001;40:381-7. https://doi.org/10.1177/000992280104000704
  14. Napoli KL, Ingall CG, Martin GR. Safety and efficacy of chloral hydrate sedation in children undergoing echocardiography. J Pediatr 1996;129:287-91. https://doi.org/10.1016/S0022-3476(96)70256-1
  15. Litman RS, Soin K, Salam A. Chloral hydrate sedation in term and preterm infants: an analysis of efficacy and complications. Anesth Analg 2010;110:739-46. https://doi.org/10.1213/ane.0b013e3181ca12a8
  16. Gilstrap LC 3rd, Leveno KJ, Burris J, Williams ML, Little BB. Diagnosis of birth asphyxia on the basis of fetal pH, Apgar score, and newborn cerebral dysfunction. Am J Obstet Gynecol 1989;161:825-30. https://doi.org/10.1016/0002-9378(89)90410-9
  17. Executive summary: neonatal encephalopathy and neurologic outcome, second edition. Report of the American College of Obstetricians and Gynecologists' Task Force on Neonatal Encephalopathy. Obstet Gynecol 2014;123:896-901. https://doi.org/10.1097/01.AOG.0000445580.65983.d2
  18. Mayers DJ, Hindmarsh KW, Sankaran K, Gorecki DK, Kasian GF. Chloral hydrate disposition following single-dose administration to critically ill neonates and children. Dev Pharmacol Ther 1991;16:71-7. https://doi.org/10.1159/000480561
  19. Malviya S, Voepel-Lewis T, Tait AR. Adverse events and risk factors associated with the sedation of children by nonanesthesiologists. Anesth Analg 1997;85:1207-13. Erratum in: Anesth Analg 1998;86:227. https://doi.org/10.1097/00000539-199712000-00005
  20. Allegaert K, Daniels H, Naulaers G, Tibboel D, Devlieger H. Pharmacodynamics of chloral hydrate in former preterm infants. Eur J Pediatr 2005;164:403-7. https://doi.org/10.1007/s00431-005-1648-5
  21. Sury M, Bullock I, Rabar S, Demott K; Guideline Development Group. Sedation for diagnostic and therapeutic procedures in children and young people: summary of NICE guidance. BMJ 2010;341:c6819. https://doi.org/10.1136/bmj.c6819